An Investigational New Drug (IND) Application for iCo-007 will be filed with the US Food and Drug Administration in 2006.  Once approved, iCo intends to initiate a clinical trial using iCo-007 for age-related macular degeneration and diabetic retinopathy.  If you are a physician or a patient interested in participating in this study, please contact us at: